London-There are signs that European rules for use of coronavirus vaccines developed by AstraZeneca and Oxford University are constantly changing and changing, causing further confusion and mistrust among citizens.
Not only did EU citizens have to fight the negative sentiment of the vaccine, even the opposition from senior officials themselves, but they also saw more than a dozen European countries suspend vaccination due to concerns about small blood reports. Blood clot.
After the European Medicines Agency and the World Health Organization conducted a security review of the data, they recommended that the injection should continue to be used, claiming that its benefits outweigh the possible risks. But these worries have not disappeared. Now the chaotic mood is overwhelming which age group should be vaccinated.
On Tuesday, Germany suspended the shooting of AstraZeneca injections on all citizens under the age of 60, citing renewed concerns after rare but serious blood clots were reported. Earlier this week, some hospitals in Berlin stopped using AstraZeneca̵
Germany initially only allowed the vaccine to be used in people under the age of 65, saying that there was insufficient data to show that the vaccine was safe and effective for the elderly, even though the vaccine was withdrawn in early March.
At the same time, Spain decided on Wednesday to expand the use of the vaccine to basic workers over 65. Prior to this, the vaccine was limited to the 55 to 65 age group, but now it will be provided to priority groups of this age group, such as health workers, police officers or teachers.
In France, people over the age of 65 were initially not allowed to use the AstraZeneca vaccine. French President Emmanuel Macron is now criticized by many French critics as armchair epidemiology, and wrongly stated that The vaccine is “ineffective” for people over 65. .
France later reversed this position with the emergence of more clinical trial data, saying that the vaccine will be allowed to be used in patients with comorbidities, including those between 65 and 74 years old.
Confused? You are not alone. Comments on Twitter indicate that both parties are confused about the official position of the vaccine.
A Twitter user from Germany pointed out that after enumerating the twists and turns of AstraZeneca’s vaccine schedule, “you can’t blame people for being confused.”
Another Aetera user based in Germany pointed out that “everyone here is confused about how good it is”, while another British Twitter user Mike Carrivick said that the reversal of the vaccine rules is “ironic irony”. “, but with potentially serious consequences. He pointed out: “No wonder many people are confused and their lives are threatened.”
Kristen Covo of London, another Twitter user, expressed confusion about AstraZeneca’s safety certificate because AstraZeneca was suspended in a few European countries, and then based on the recommendations of EMA and WHO Reuse.
Regarding the issue of giving the second dose of vaccine to young people who have already received the first dose of AstraZeneca vaccine, the German Vaccine Board said it will issue guidance on this matter before the end of April.
The accompanying narrative (and major controversy) of vaccination has made the contradictory and changing attitudes towards vaccines in European countries even more confusing.
The EU has repeatedly criticized the drug manufacturer for failing to meet its delivery schedule. At the same time, various EU officials and leaders have questioned the efficacy of the vaccine, which in turn has prompted many EU citizens to doubt the vaccine. .
A BBC reporter in Brussels pointed out that after cheap grocery stores, it was labelled “Aldi vaccine” because people used vaccination as a budget option. There are other reports that people are asking for Pfizer-BioNTech or Moderna injections instead of AstraZeneca vaccines.
As a British Twitter user named gazztrade questioned on Wednesday, is the EU “willing to use the AstraZeneca vaccine?”
The data compiled by the WHO shows that so far, only 10% of the total European population has received a single vaccination, while 4% have completed a complete vaccination. The United Nations health agency called the introduction of vaccines in the region “unacceptably slow.”